Initial experience with octreotide in the pediatric population

American Journal of Therapeutics

Volumn 8, Issue 6, 2001, Pages 409-415

  Tobias, Joseph D ^a  

^a University of Missouri   (United States)

Author keywords

Chylothorax; GI hemorrhage; Octreotide; Pancreatitis

Indexed keywords

GASTROINTESTINAL AGENT; HEMOSTATIC AGENT; OCTREOTIDE;

ADOLESCENT; ARTICLE; CHILD; DRUG ADMINISTRATION; ESOPHAGUS DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INFANT; MALE; MEDICAL RECORD; NEWBORN; PANCREAS DISEASE; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL DISEASES; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HEMOSTATICS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL RECORDS; OCTREOTIDE; PANCREATIC DISEASES; RETROSPECTIVE STUDIES;

EID: 0035513623     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200111000-00005     Document Type: Article

References (4)

1. Mulvihill S, Pappas TN, Passaro E, et al: The use of somatostatin and its analogs in the treatment of surgical disorders. Surgery 1986;100:467-475.
2. Siafakas C, Fox VL, Nurko S: Use of octreotide for the treatment of severe gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 1998;26:356-359.
3. Tauber MT, Harris AG, Rochiccioli P: Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr 1994;153:304-310.
4. Rushforth JA, Beck JM, McMahon M, et al: Resolution of pancreatic ascites with octreotide. Arch Dis Child 1993;68:135-136.